Search alternatives:
significant challenges » significant challenge (Expand Search), significant changes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenges decrease » challenges case (Expand Search)
Showing 1,821 - 1,840 results of 21,342 for search '(( significant decrease decrease ) OR ( significant challenges decrease ))', query time: 0.37s Refine Results
  1. 1821
    Column charts of SI<sub>8min</sub> and SI<sub>10min</sub> in the therapy and control group at follow-up.

    Column charts of SI<sub>8min</sub> and SI<sub>10min</sub> in the therapy and control group at follow-up. by Felix L. Herr (21544362)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1822
    Representative immunohistochemical stainings.

    Representative immunohistochemical stainings. by Felix L. Herr (21544362)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1823
    Experimental design.

    Experimental design. by Felix L. Herr (21544362)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1824
    ROI selection.

    ROI selection. by Felix L. Herr (21544362)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1825
    Column charts of WiAUC in therapy and control group at baseline and follow-up.

    Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1826
    Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx

    Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
    Save to List
    Saved in:
  7. 1827
    Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx

    Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
    Save to List
    Saved in:
  8. 1828
    Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx

    Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

    Published 2024
    “…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
    Save to List
    Saved in:
  9. 1829
    Group control-after intervention.

    Group control-after intervention. by Nan Tang (642590)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1830
    Flowchart of literature screening process.

    Flowchart of literature screening process. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1831
    Seasonal Influenza activity from 2020-2023 in Southeast Asia and Southern Asia.

    Seasonal Influenza activity from 2020-2023 in Southeast Asia and Southern Asia. by Nadia Nisar (311028)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1832
    The details of literature inclusion and exclusion.

    The details of literature inclusion and exclusion. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1833
    Samples Tested and Positive Samples During Pre- and Post-Pandemic Periods.

    Samples Tested and Positive Samples During Pre- and Post-Pandemic Periods. by Nadia Nisar (311028)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1834
    Group SFA-before intervention.

    Group SFA-before intervention. by Nan Tang (642590)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1835
    Seasonal Influenza activity from 2017-2023 in SEAR and WPR region.

    Seasonal Influenza activity from 2017-2023 in SEAR and WPR region. by Nadia Nisar (311028)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1836
    Comparison of ten Asian countries with pre and post pandemic influenza activity sources through Flunet.

    Comparison of ten Asian countries with pre and post pandemic influenza activity sources through Flunet. by Nadia Nisar (311028)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1837
    Lost cases.

    Lost cases. by Nan Tang (642590)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1838
    Basic characteristics of included literature.

    Basic characteristics of included literature. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1839
    Baseline sociodemographic data and disease-related variables of two groups (n = 105).

    Baseline sociodemographic data and disease-related variables of two groups (n = 105). by Nan Tang (642590)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1840
    Analysis of SAS, SDS, PSQI, and FertiQoL scores.

    Analysis of SAS, SDS, PSQI, and FertiQoL scores. by Nan Tang (642590)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: